[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Li et al., 2017 - Google Patents

Quantitative imaging for targeted radionuclide therapy dosimetry-technical review

Li et al., 2017

View HTML
Document ID
807143520902321757
Author
Li T
Ao E
Lambert B
Brans B
Vandenberghe S
Mok G
Publication year
Publication venue
Theranostics

External Links

Snippet

Targeted radionuclide therapy (TRT) is a promising technique for cancer therapy. However, in order to deliver the required dose to the tumor, minimize potential toxicity in normal organs, as well as monitor therapeutic effects, it is important to assess the individualized …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/29—Measurement performed on radiation beams, e.g. position or section of the beam; Measurement of spatial distribution of radiation
    • G01T1/2914—Measurement of spatial distribution of radiation
    • G01T1/2985—In depth localisation, e.g. using positron emitters; Tomographic imaging (longitudinal and transverse section imaging; apparatus for radiation diagnosis sequentially in different planes, steroscopic radiation diagnosis)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
    • A61K51/1003—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/16—Measuring radiation intensity
    • G01T1/161—Application in the field of nuclear medicine, e.g. in vivo counting
    • G01T1/164—Scintigraphy
    • G01T1/1641—Static instruments for imaging the distribution of radioactivity in one or two dimensions using one or several scintillating elements; Radio-isotope cameras
    • G01T1/1648—Ancillary equipment for scintillation cameras, e.g. reference markers, devices for removing motion artifacts, calibration devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T11/00—2D [Two Dimensional] image generation
    • G06T11/003—Reconstruction from projections, e.g. tomography
    • G06T11/005—Specific pre-processing for tomographic reconstruction, e.g. calibration, source positioning, rebinning, scatter correction, retrospective gating
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems

Similar Documents

Publication Publication Date Title
Li et al. Quantitative imaging for targeted radionuclide therapy dosimetry-technical review
Conti et al. Physics of pure and non-pure positron emitters for PET: a review and a discussion
Dewaraja et al. MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy
Elschot et al. 99m Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166 Ho-microspheres
Hippeläinen et al. Quantitative accuracy of 177 Lu SPECT reconstruction using different compensation methods: phantom and patient studies
Frey et al. Accuracy and precision of radioactivity quantification in nuclear medicine images
Zaidi et al. Determination of the attenuation map in emission tomography
Elschot et al. Quantitative monte carlo–based 90y spect reconstruction
Walrand et al. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86
Ljungberg et al. 3-D image-based dosimetry in radionuclide therapy
Elschot et al. Quantitative Monte Carlo‐based holmium‐166 SPECT reconstruction
Bailey et al. In vivo quantification of 177 Lu with planar whole-body and SPECT/CT gamma camera imaging
Marquis et al. Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
Delker et al. Biodistribution and dosimetry for combined [177Lu] Lu-PSMA-I&T/[225Ac] Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Sarrut et al. 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma
Ao et al. Improved dosimetry for targeted radionuclide therapy using nonrigid registration on sequential SPECT images
Li et al. BIGDOSE: software for 3D personalized targeted radionuclide therapy dosimetry
Ramonaheng et al. The effect of calibration factors and recovery coefficients on 177 Lu SPECT activity quantification accuracy: a Monte Carlo study
van der Have et al. High-resolution clustered pinhole 131Iodine SPECT imaging in mice
Dewaraja et al. Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study
Gregory et al. Optimization and assessment of quantitative 124 I imaging on a Philips Gemini dual GS PET/CT system
Herzog In vivo functional imaging with SPECT and PET
Walrand et al. Bremsstrahlung SPECT/CT
Blaickner et al. Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy
Shcherbinin et al. Three-dimensional personalized dosimetry for 188Re liver selective internal radiation therapy based on quantitative post-treatment SPECT studies